The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder
- 31 August 1996
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 6 (3) , 187-194
- https://doi.org/10.1016/0924-977x(96)00018-1
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Pentagastrin infusions in patients with panic disorder II. NeuroendocrinologyBiological Psychiatry, 1994
- The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic DisorderArchives of General Psychiatry, 1994
- Vagal attenuation in panic disorder: an assessment of parasympathetic nervous system function and subjective reactivity to respiratory manipulations.Psychosomatic Medicine, 1994
- The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-mazePsychopharmacology, 1993
- A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorderBiological Psychiatry, 1992
- Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic DisorderArchives of General Psychiatry, 1991
- Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorderBiological Psychiatry, 1991
- Cholecystokinin-4 and PanicArchives of General Psychiatry, 1990
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- Assessment of fear of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire.Journal of Consulting and Clinical Psychology, 1984